Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

770 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries.
Furl R, Scarsi KK, Sayles H, Anderson M, Ofimboudem JD, Weld ED, Waked I, Gomaa A, Al-Khatib A, Elshobary FM, Desalegn H, Fisseha H, Solomon S, Mehta S, Owen A, Rannard S, Thomas DL, Swindells S. Furl R, et al. Among authors: thomas dl. J Viral Hepat. 2024 Nov 15. doi: 10.1111/jvh.14031. Online ahead of print. J Viral Hepat. 2024. PMID: 39545599
Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT).
Solomon SS, Sulkowski MS, Amrose P, Srikrishnan AK, McFall AM, Ramasamy B, Kumar MS, Anand S, Thomas DL, Mehta SH. Solomon SS, et al. Among authors: thomas dl. J Viral Hepat. 2018 Jan;25(1):37-46. doi: 10.1111/jvh.12761. Epub 2017 Aug 14. J Viral Hepat. 2018. PMID: 28719029 Free PMC article. Clinical Trial.
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.
Weld ED, Astemborski J, Kirk GD, Sulkowski MS, Katz S, Rothman R, Solomon SS, Matthews GV, Hsieh YH, Verma M, Traverso G, Swindells S, Owen A, Feld J, Flexner C, Mehta SH, Thomas DL. Weld ED, et al. Among authors: thomas dl. Clin Infect Dis. 2022 Aug 24;75(1):3-10. doi: 10.1093/cid/ciab913. Clin Infect Dis. 2022. PMID: 34699587 Free PMC article.
Prospects for Long-Acting Treatments for Hepatitis C.
Thomas DL, Owen A, Kiser JJ. Thomas DL, et al. Clin Infect Dis. 2022 Nov 21;75(Suppl 4):S525-S529. doi: 10.1093/cid/ciac715. Clin Infect Dis. 2022. PMID: 36410380 Free PMC article.
Public health clinic-based hepatitis C testing and linkage to care in Baltimore.
Falade-Nwulia O, Mehta SH, Lasola J, Latkin C, Niculescu A, O'Connor C, Chaulk P, Ghanem K, Page KR, Sulkowski MS, Thomas DL. Falade-Nwulia O, et al. Among authors: thomas dl. J Viral Hepat. 2016 May;23(5):366-74. doi: 10.1111/jvh.12507. Epub 2016 Feb 3. J Viral Hepat. 2016. PMID: 26840570 Free PMC article.
Doing the math on hepatitis C virus treatment.
Mehta SH, Thomas DL. Mehta SH, et al. Among authors: thomas dl. J Hepatol. 2016 Jul;65(1):5-6. doi: 10.1016/j.jhep.2016.03.015. Epub 2016 Apr 2. J Hepatol. 2016. PMID: 27050632 Free PMC article. No abstract available.
770 results